About Creoptix
Creoptix is a Technology company based in Wadenswil (Switzerland) founded in 2009, and was acquired by Malvern Panalytical in January 2022. Instruments for high-sensitivity label-free molecular interactions analysis are developed. It operates in the Technology and Healthcare sectors. Creoptix has raised $11.33 million across 2 funding rounds from investors including Zurcher Kantonalbank, Waters Corporation and Malvern Panalytical. The company was acqui-hired. Its focus areas include Semiconductors, Photonics, Biophotonics and Analytics and Sensing.
Company details
Creoptix was founded in 2009 in Wadenswil, Switzerland, within the biotechnology sector. Optical instruments and consumables based on Grating-Coupled Interferometry technology are produced for label-free molecular interaction analysis. Sets for fragment-based screening and binding studies at low concentrations are offered, alongside carboxyl-coupling sensors suitable for various molecules. Software for integrated assay setup and data evaluation is also provided to support these operations.
- Headquarters Wadenswil, Switzerland
- Stage Acquired
- SectorsTechnologyHealthcare
- Email••••••••
- Website creoptix.com
- Social LinkedIn X
- Acquired by Malvern Panalytical (Jan 2022)
- Total Equity Funding$11.33M (USD)
in 2 rounds
- Latest Funding Round$8.04M (USD), Series C
Sep 2019
- InvestorsZurcher Kantonalbank
& 5 more
- Acquired byMalvern Panalytical
(Jan 2022)
Funding Insights of Creoptix
Creoptix has successfully raised a total of $11.33M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $8.04 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.33M
- Total Rounds 2
- Last Round Series C — $8.04M
- First Round $3.29M
(Nov 2013)
- Investors Count 5
All 2 funding rounds of Creoptix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2019 | $8.04M | Series C | – | Swisscanto | |
| Nov 2013 | $3.29M | Series A | – | – |
6 investors in total: 6 institutional.
Investors in Creoptix
Creoptix has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Zurcher Kantonalbank, Waters Corporation and Malvern Panalytical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
StartAngels Network is operated as a non-profit association connecting angel investors with Swiss startups. | 1999 | startangels.ch | Zürich, Switzerland | |
Provider of laboratory management system for researchers and clinicians | 1958 | waters.com | Milford, United States | |
Swisscanto is recognized as a leading fund manager in Switzerland. | swisscanto.ch | Switzerland | ||
Commercial banking services are provided across Switzerland by Zurcher Kantonalbank. | 1870 | zkb.ch | Zurich, Switzerland | |
Operates as a commercial bank providing deposits, loans, and payment services. | kantonalbank.ch | Basel, Switzerland | ||
Medical instruments are manufactured for multiple industries through R&D. | 2017 | malvernpanalytical.com | Almelo, Netherlands |
Investor details for Creoptix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Creoptix
4 dated milestones of Creoptix across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Creoptix is founded.
- Funding First funding round of $3.3M.
- Funding Latest funding round, Series C, of $8.0M.
- Exit Acquired by Malvern Panalytical.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Creoptix
Complete news archive for Creoptix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Creoptix
Creoptix was founded in 2009 and raised its 1st funding round 4 years after it was founded.
Creoptix is headquartered in Wadenswil, Switzerland. It is registered at Wadenswil, Zurich, Switzerland.
Creoptix is a funded company, having raised a total of $11.33M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.29M, raised on Nov 2013.
Creoptix was founded in 2009 in Wadenswil, Switzerland, within the biotechnology sector. Optical instruments and consumables based on Grating-Coupled Interferometry technology are produced for label-free molecular interaction analysis. Sets for fragment-based screening and binding studies at low concentrations are offered, alongside carboxyl-coupling sensors suitable for various molecules. Software for integrated assay setup and data evaluation is also provided to support these operations.
Creoptix has 6 investors. Key investors include Zurcher Kantonalbank, Waters Corporation, Malvern Panalytical, Swisscanto, and StartAngels Network.
Yes. Creoptix was acquired by Malvern Panalytical in January 2022.